Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

How does tigecycline's metabolism impact liver function?

See the DrugPatentWatch profile for tigecycline

Tigecycline’s effects on the liver are mostly tied to how it’s handled by the body, but—clinically—it’s not known for causing liver injury through metabolism in the way many other antibiotics can.

1) How tigecycline is metabolized/cleared

  • Metabolism: Tigecycline is metabolized in the body to several inactive metabolites (it’s primarily processed by the liver through metabolic pathways rather than being excreted unchanged).
  • Excretion: A large portion is eliminated via the biliary/fecal route, with some elimination via urine.

2) What that means for liver function

Because tigecycline relies partly on hepatic/biliary processing, people with liver impairment can have higher exposure to the drug:
- In mild to moderate hepatic impairment, tigecycline exposure tends to increase.
- In severe hepatic impairment, exposure increases more noticeably, and this can raise the risk of side effects, even if it doesn’t directly “damage” the liver via its metabolism.

Clinical implication: Liver impairment is mainly a dose-exposure issue rather than a well-known, direct hepatotoxic-metabolism mechanism.

3) Does tigecycline itself cause liver injury?

  • Tigecycline can cause elevations in liver enzymes (e.g., AST/ALT, alkaline phosphatase, bilirubin) in some patients.
  • These changes are often transient and not always accompanied by clinically significant liver failure.
  • However, monitoring is recommended, especially in patients who already have abnormal liver tests, cholestasis, or those on other hepatotoxic medications.

4) Practical monitoring

If someone is receiving tigecycline (especially with baseline liver disease):
- Check baseline LFTs (AST/ALT, bilirubin, alkaline phosphatase)
- Recheck periodically during therapy
- Be alert for cholestatic patterns or rising bilirubin, and stop/escalate evaluation if clinically significant liver injury is suspected.

---

If you tell me the context (e.g., “mild vs severe hepatic impairment,” baseline bilirubin/AST/ALT, and whether the question is for dosing or toxicity concern), I can tailor the explanation to that scenario.



Other Questions About Tigecycline :

law office was in charge of lawsuit of a patent for generic tigecycline for injection Has tigecycline misuse been linked to fatalities? Can excessive tigecycline usage worsen bacterial resistance? Can tigecycline overdose worsen antibiotic resistance? Can you remind me of the typical tigecycline dose by itself? Are there alternatives to tigecycline for infection treatment? Is tigecycline s liver risk dose dependent?